Home | GSK
At GSK, we unite science, technology and talent to get ahead of disease together
Home | GSK US
January 07 2025 GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma December 16 2024 Jemperli (dostarlimab-gxly) receives US FDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer
GlaxoSmithKline Pharmaceuticals - Wikipedia
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [4] [5] The company's product portfolio includes prescription medicines and vaccines.
At a glance | GSK US
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US; Our largest US-based operation, the Upper Providence R&D hub features 8 smart labs and more than 3,000 GSK people discovering and developing new medicines which will change lives.
GSK plc - Wikipedia
GSK is the tenth largest pharmaceutical company and No. 294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck Sharp & Dohme.
GlaxoSmithKline Company Information - Drugs.com
Aug 1, 2024 · GlaxoSmithKline manufactures, markets and/or distributes more than 64 drugs in the U.S.
Products - GSK US
We deliver over 1.5 million doses of our vaccines every day; and 4 out of 10 infants born each year receive at least one GSK vaccine. Our vaccines portfolio targets infectious diseases at every stage of life, helping to protect people from RSV, meningitis, shingles, flu, polio and many more.
Products - GSK
We deliver over 1.5 million doses of our vaccines every day; and 4 out of 10 infants born each year receive at least one GSK vaccine. Our vaccines portfolio targets infectious diseases at every stage of life, helping to protect people from RSV, meningitis, shingles, flu, polio and many more.
Home | GSK India
Here at GSK, we unite science, technology and talent to get ahead of disease together. We are committed to doing the right thing: our ambition is to improve the lives of billions across the world. By bringing together outstanding people, doing work that matters in an inclusive environment, so we can make an impact on a global scale.
Pipeline - GSK
At GSK, our portfolio and pipeline is focused in developing vaccines and medicines in four core therapeutic areas, which are the areas of human health we focus on to prevent and treat disease: infectious diseases, HIV, respiratory/immunology and oncology.